Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes

Clinical Biochemistry

Volumn 45, Issue 16-17, 2012, Pages 1432-1438

  Monickaraj, Finny ^a   Gokulakrishnan, Kuppan ^a   Prabu, Paramasivam ^a   Sathishkumar, Chandrakumar ^a   Anjana, Ranjit Mohan ^a   Rajkumar, Janavikula Sankaran ^b   Mohan, Viswanathan ^a   Balasubramanyam, Muthuswamy ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b LifeLine Multi Speciality Hospitals   (India)

Author keywords

Adipocyte hypertrophy; Hypoadiponectinemia; Metabolic obesity; Telomere shortening; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOADIPONECTINEMIA; INTRAABDOMINAL FAT; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TELOMERE SHORTENING; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; CELL SIZE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTROPHY; INTRA-ABDOMINAL FAT; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED; OBESITY; RISK FACTORS; SUBCUTANEOUS FAT; TELOMERE SHORTENING; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84868302299     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.07.097     Document Type: Article

References (40)

1. Misra A., Khurana L. Obesity-related non-communicable diseases: south Asians vs White Caucasians. Int J Obes (Lond) 2011, 35:167-187.
2. Razak F., Anand S.S., Shannon H., Vuksan V., Davis B., Jacobs R., et al. Defining obesity cut points in a multiethnic population. Circulation 2007, 115:2111-2118.
3. Matsushita Y., Nakagawa T., Yamamoto S., Takahashi Y., Yokoyama T., Noda M., et al. Associations of visceral and subcutaneous fat areas with the prevalence of metabolic risk factor clustering in 6,292 Japanese individuals: the Hitachi Health Study. Diabetes Care 2010, 33:2117-2119.
4. Bays H.E., Fox K.M., Grandy S. SHIELD study group, anthropometric measurements and diabetes mellitus: clues to the "pathogenic" and "protective" potential of adipose tissue. Metab Syndr Relat Disord 2010, 8:307-315.
5. Lönn M., Mehlig K., Bengtsson C., Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2010, 24:326-331.
6. Lundgren M., Svensson M., Lindmark S., Renstrom F., Ruge T., Eriksson J.W. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007, 50:625-633.
7. Adaikalakoteswari A., Balasubramanyam M., Mohan V. Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med 2005, 22:1151-1156.
8. Adaikalakoteswari A., Balasubramanyam M., Ravikumar R., Deepa R., Mohan V. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis 2007, 195:83-89.
9. Balasubramanyam M., Adaikalakoteswari A., Monickaraj S.F., Mohan V. Telomere shortening & metabolic/vascular diseases. Indian J Med Res 2007, 125:441-450.
10. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30:e47.
11. Salans L.B., Knittle J.L., Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 1968, 47:153-165.
12. Jernås M., Palming J., Sjöholm K., Jennische E., Svensson P.A., Gabrielsson B.G., et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006, 20:1540-1542.
13. Franck N., Stenkula K.G., Ost A., Lindström T., Strålfors P., Nystrom F.H. Insulin induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia 2007, 50:1716-1722.
14. Skurk T., Alberti-Huber C., Herder C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007, 92:1023-1033.
15. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
16. Shadid S., Jensen M.D. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003, 26:3148-3152.
17. Wueest S., Rapold R.A., Rytka J.M., Schoenle E.J., Konrad D. Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. Diabetologia 2009, 52:541-546.
18. Pasarica M., Tchoukalova Y.D., Heilbronn L.K., Fang X., Albu J.B., Kelley D.E., et al. Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring) 2009, 17:1976-1978.
19. Yang J., Eliasson B., Smith U., Cushman S.W., Sherman A.S. The Size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity (Silver Spring) 2012, 20:932-938.
20. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43:1498-1506.
21. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
22. Rhee D.B., Ghosh A., Lu J., Bohr V.A., Liu Y. Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair (Amst) 2011, 10:34-44.
23. Nordfjäll K., Eliasson M., Stegmayr B., Melander O., Nilsson P., Roos G. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 2008, 16:2682-2689.
24. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
25. Lee M., Martin H., Firpo M.A., Demerath E.W. Inverse association between adiposity and telomere length: the Fels Longitudinal Study. Am J Hum Biol 2011, 23:100-106.
26. Moreno-Navarrete J.M., Ortega F., Sabater M., Ricart W., Fernández-Real J.M. Telomere length of subcutaneous adipose tissue cells is shorter in obese and formerly obese subjects. Int J Obes (Lond) 2010, 34:1345-1348.
27. Njajou O.T., Cawthon R.M., Blackburn E.H., Harris T.B., Li R., Sanders J.L., et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond) 2011, 10.1038/ijo.2011.196.
28. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56:1010-1013.
29. Mohan V., Deepa R., Pradeepa R., Vimaleswaran K.S., Mohan A., Velmurugan K., et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005, 54:476-481.
30. Wasim H., Al-Daghri N.M., Chetty R., McTernan P.G., Barnett A.H., Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol 2006, 5:10.
31. Sandhya N., Gokulakrishnan K., Ravikumar R., Mohan V., Balasubramanyam M. Association of hypoadiponectinemia with hypoglutathionemia in NAFLD subjects with and without type 2 diabetes. Dis Markers 2010, 29:213-221.
32. Al-Attas O.S., Al-Daghri N.M., Alokail M.S., Alfadda A., Bamakhramah A., Sabico S., et al. Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol 2010, 163:601-607.
33. Chang J., Li Y., Huang Y., Lam K.S., Hoo R.L., Wong W.T., et al. Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes 2010, 59:2949-2959.
34. Wood I.S., de Heredia F.P., Wang B., Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009, 68:370-377.
35. Chandalia M., Lin P., Seenivasan T., Livingston E.H., Snell P.G., Grundy S.M., et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One 2007, 2:e812.
36. Anand S.S., Tarnopolsky M.A., Rashid S., Schulze K.M., Desai D., Mente A., et al. Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS One 2011, 6:e22112.
37. Deurenberg-Yap M., Schmidt G., van Staveren W.A., Deurenberg The P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord 2000, 24:1011-1017.
38. Shah A., Hernandez A., Mathur D., Budoff M.J., Kanaya A.M. Adipokines and body fat composition in South Asians: results of the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study. Int J Obes (Lond) 2012, 36:810-816.
39. Sniderman A.D., Bhopal R., Prabhakaran D., Sarrafzadegan N., Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 2007, 36:220-225.
40. Henry S.L., Bensley J.G., Wood-Bradley R.J., Cullen-McEwen L.A., Bertram J.F., Armitage J.A. White adipocytes: more than just fat depots. Int J Biochem Cell Biol 2012, 44:435-440.